|
Code Type
|
Code
|
Effective*
|
|
Testing (CDC)
|
U0001
|
2/4/2020
|
|
Testing (Non-CDC)
|
U0002
|
2/4/2020
|
|
Testing (Industry Standard)
|
87635
|
3/13/2020
|
|
Testing (Infectious
Disease)
|
0202U
|
5/20/2020
|
|
Testing (Throughput)
|
U0003
|
4/14/2020
|
|
Testing (Throughput)
|
U0004
|
4/14/2020
|
|
Testing (Antigen)
|
0223U
|
6/25/2020
|
|
Testing (Antigen)
|
0224U
|
6/25/2020
|
|
Testing (Infectious
Disease)
|
0225U
|
8/10/2020
|
|
Testing (sVNT)
|
0226U
|
8/10/2020
|
|
Testing
|
86413
|
9/8/2020
|
|
Testing (Infectious
Disease)
|
0240U
|
10/6/2020
|
|
Testing (Infectious
Disease)
|
0241U
|
10/6/2020
|
|
Testing (Infectious Agent
Detection)
|
87636
|
10/6/2020
|
|
Testing (Infectious Agent
Detection)
|
87637
|
10/6/2020
|
|
Testing (Infectious Agent
Detection)
|
87811
|
10/6/2020
|
|
Mutation identification
SARS CoV-2
|
87913
|
2/21/2022
|
|
Testing (Add-On Payment)
|
U0005
|
1/1/2021
|
|
OTC At Home COVID Tests
|
N/A
|
1/15/2022
|
|
Screening
|
Z03.818
|
2/4/2020
|
|
Screening (Specimen
Transfer)
|
G2023
|
3/1/2020
|
|
Screening (Specimen
Transfer)
|
G2024
|
3/1/2020
|
|
Screening (Specimen Transfer)
|
C9803
|
3/1/2020
|
|
Screening (Antibody
Testing)
|
86328
|
4/10/2020
|
|
Screening (Antibody
Testing)
|
86769
|
4/10/2020
|
|
Screening (Antigen
Detection)
|
87426
|
6/25/2020
|
|
Screening (Antigen
Detection)
|
87428
|
11/10/2020
|
|
Screening (Neutralizing
Antibody)
|
86408
|
8/10/2020
|
|
Screening (Neutralizing
Antibody)
|
86409
|
8/10/2020
|
|
Encounter for Screening
COVID-19
|
Z11.52
|
1/1/2021
|
|
Contact with and
(suspected) exposure to COVID-19
|
Z20.822
|
1/1/2021
|
|
VEKLURY Antiviral
Medication
|
J0248
|
12/23/2021
|
|
Convalescent Plasma
|
C9507
|
12/28/2021
|
|
Multisystem inflammatory
syndrome (MIS)
|
M35.81
|
1/1/2021
|
|
Treatment
|
U07.1
|
4/1/2020
|
|
Treatment
|
B97.29
|
1/27/2020-3/31/2020
|
|
AstraZeneca – Tixagev and
Cilgav Injection
|
Q0220
|
12/8/2021
|
|
AstraZeneca – Tixagev and Cilgav
Injection
|
M0220
|
12/8/2021
|
|
AstraZeneca – Tixagev and
Cilgav Injection
|
M0221
|
12/8/2021
|
|
AstraZeneca – Tixagev and
Cilgav Injection
|
Q0221
|
2/24/2022
|
|
Eli Lily – Bebtelovimab
Injection
|
Q0222
|
2/11/2022
|
|
Eli Lily – Bebtelovimab
Injection
|
M0222
|
2/11/2022
|
|
Eli Lily – Bebtelovimab
Injection
|
M0223
|
2/11/2022
|
|
Eli Lily Monoclonal -
Bamlan/Etesev Injection
|
Q0245
|
2/9/2021
|
|
Eli Lily Monoclonal -
Bamlan/Etesev Infusion
|
M0245*
|
2/9/2021
|
|
Eli Lily Monoclonal -
Bamlan/Etesev Infusion
|
M0246
|
5/6/2021
|
|
GSK Monoclonal - Sotrov
Injection
|
Q0247
|
5/26/2021
|
|
GSK Monoclonal - Sotrov
Infusion
|
M0247*
|
5/26/2021
|
|
GSK Monoclonal - Sotrov
Infusion In Home
|
M0248
|
5/26/2021
|
|
Genentech Monoclonal -
Tocili Injection
|
Q0249
|
6/24/2021
|
|
Genentech Monoclonal -
Tocili 1st Infusion
|
M0249*
|
6/24/2021
|
|
Genentech Monoclonal -
Tocili 2nd Infusion
|
M0250*
|
6/24/2021
|
|
Eli Lily Monoclonal -
Bamlan Injection
|
Q0239
|
11/10/2020 - 5/6/21
|
|
Eli Lily Monoclonal -
Bamlan Infusion
|
M0239*
|
11/10/2020 - 5/6/21
|
|
Regeneron Monoclonal - Casiri/Imdev
Injection
|
Q0243
|
11/21/2020-1/23/22
|
|
Regeneron Monoclonal -
Casiri/Imdev Infusion
|
M0243*
|
11/21/2020-1/23/22
|
|
Regeneron Monoclonal -
Casiri/Imdev Injection
|
Q0244
|
6/3/2021-1/23/22
|
|
Regeneron Monoclonal -
Casiri/Imdev Infusion
|
M0244
|
5/6/2021-1/23/22
|
|
Regeneron Monoclonal -
Casiri/Imdev Injection
|
Q0240
|
7/30/2021-1/23/22
|
|
Regeneron Monoclonal -
Casiri/Imdev Infusion
|
M0240
|
7/30/2021-1/23/22
|
|
Regeneron Monoclonal -
Casiri/Imdev Infusion
|
M0241
|
7/30/2021-1/23/22
|
|
Home Vaccine Admin
|
M0201
|
6/8/2021
|
|
Pfizer Vaccine
|
91300
|
12/11/2020
|
|
Pfizer Vaccine Admin - 1st
Dose
|
0001A
|
12/11/2020
|
|
Pfizer Vaccine Admin - 2nd
Dose
|
0002A
|
12/11/2020
|
|
Pfizer Vaccine Admin - 3rd
Dose
|
0003A
|
8/12/2021
|
|
Pfizer Vaccine Admin -
Booster
|
0004A
|
9/22/2021
|
|
Moderna Vaccine
|
91301
|
12/18/2020
|
|
Moderna Vaccine Admin - 1st
Dose
|
0011A
|
12/18/2020
|
|
Moderna Vaccine Admin - 2nd
Dose
|
0012A
|
12/18/2020
|
|
Moderna Vaccine Admin - 3rd
Dose
|
0013A
|
8/12/2021
|
|
Moderna Vaccine (Low Dose)
|
91306
|
10/20/2021
|
|
Moderna Vaccine (Low Dose)
- Booster
|
0064A
|
10/20/2021
|
|
Janssen Vaccine
|
91303
|
2/27/2021
|
|
Janssen Vaccine Admin -
Single Dose
|
0031A
|
2/27/2021
|
|
Janssen Vaccine Admin –
Booster
|
0034A
|
10/20/21
|
|
Pfizer Vaccine (Pediatric)
|
91307
|
10/29/2021
|
|
Pfizer Vaccine (Pediatric)
Admin - 1st Dose
|
0071A
|
10/29/2021
|
|
Pfizer Vaccine (Pediatric)
Admin - 2nd Dose
|
0072A
|
10/29/2021
|
|
Pfizer SARS-COV2 Vaccine,
mRNA-LNP 10MCG/0.2mL for 5 - 11 years - Booster
|
0074A
|
5/17/2022
|
|
Pfizer Vaccine (Ready to
use)
|
91305
|
1/3/2022
|
|
Pfizer Vaccine (Ready to
use) Admin - 1st Dose
|
0051A
|
1/3/2022
|
|
Pfizer Vaccine (Ready to
use) Admin - 2nd Dose
|
0052A
|
1/3/2022
|
|
Pfizer Vaccine (Ready to
use) Admin - 3rd Dose
|
0053A
|
1/3/2022
|
|
Pfizer Vaccine (Ready to
use) Admin – Booster
|
0054A
|
1/3/2022
|
|
Moderna COVID-19 Vaccine 50MCG/0.5ML – Booster Administration
|
0094A
|
3/7/2022
|
|
Moderna SARS-COV2 Vaccine,
mRNA-LNP 50MCG/0.5mL 6 years – 11 years
|
91309
|
3/7/2022
|
|
Pfizer -SARS-COV2 Vaccine,
mRNA-LNP 3MCG/0.2mL for 6 months – 5 years – 1st Dose Administration
|
0081A
|
2/2/2022
|
|
Pfizer - SARS-COV2 Vaccine,
mRNA-LNP 3MCG/0.2mL for 6 months – 5 years – 2nd Dose Administration
|
0082A
|
2/1/2022
|
|
Pfizer -SARS-COV2 Vaccine,
mRNA-LNP 3MCG/0.2mL for 6 months – 5 years
|
91308
|
2/1/2022
|
|
NEW - Moderna Covid-19
Pediatric Vaccine 6 months - 5 years 250MCG/0.25ML
|
91311
|
7/1/2022
|
|
NEW - Moderna Covid-19
Pediatric Vaccine 6 months - 5 years Administration – 1st dose
|
0111A
|
7/1/2022
|
|
NEW - Moderna Covid-19
Pediatric Vaccine 6 months - 5 years Administration – 2nd dose
|
0112A
|
7/1/2022
|